New Breast Cancer Staging System Emphasizes Importance of Tumor Biology as Prognostic Indicator

A new breast cancer staging system developed by researchers at The University of Texas MD Anderson Cancer Center finds that incorporating tumor biology is a critical prognostic indicator for women who undergo neoadjuvant, or pre-surgical, therapy for breast cancer.